Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon G Adler

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|August 10, 2022
Dual therapy with an angiotensin receptor blocker and a JAK1/2 inhibitor attenuates dialysate-induced angiogenesis and preserves peritoneal membrane structure and function in an experimental CKD rat modelPei Zhang, Kana N Miyata, Cynthia C Nast, et al.
Journal of the American Society of Nephrology : JASN|February 1, 2008
Products of 12/15-lipoxygenase upregulate the angiotensin II receptorZhong-Gao Xu, Hang Yuan, Linda Lanting, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2002
Can glomerular mRNAs in human type 1 diabetes be used to predict transition from normoalbuminuria to microalbuminuria?Sharon G Adler, Shin-Wook Kang, Stella Feld, et al.
Kidney International|August 7, 2009
Chronic kidney disease, hypovitaminosis D, and mortality in the United StatesRajnish Mehrotra, Dulcie A Kermah, Isidro B Salusky, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 14, 2004
12/15-lipoxygenase inhibitors in diabetic nephropathy in the ratJun Ma, Rama Natarajan, Janine LaPage, et al.
Kidney International|February 9, 2005
Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruliZhong-Gao Xu, Tae-Hyun Yoo, Dong-Ryeol Ryu, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 5, 2010
Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuriaSharon G Adler, Sherwyn Schwartz, Mark E Williams, et al.
Glomerular Diseases|May 8, 2026
Prediabetes in Children and Adults with Glomerular DiseaseWilliam Rasmussen, Kayla Sifre, Nathaniel Putnam, et al.
Kidney International|August 17, 2016
The relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseasesMarie C Hogan, Heather N Reich, Peter J Nelson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 20, 2010
Examination of association with candidate genes for diabetic nephropathy in a Mexican American populationSulgi Kim, Hanna E Abboud, Madeleine V Pahl, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|August 10, 2022
Dual therapy with an angiotensin receptor blocker and a JAK1/2 inhibitor attenuates dialysate-induced angiogenesis and preserves peritoneal membrane structure and function in an experimental CKD rat modelPei Zhang, Kana N Miyata, Cynthia C Nast, et al.
Journal of the American Society of Nephrology : JASN|February 1, 2008
Products of 12/15-lipoxygenase upregulate the angiotensin II receptorZhong-Gao Xu, Hang Yuan, Linda Lanting, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 28, 2002
Can glomerular mRNAs in human type 1 diabetes be used to predict transition from normoalbuminuria to microalbuminuria?Sharon G Adler, Shin-Wook Kang, Stella Feld, et al.
Kidney International|August 7, 2009
Chronic kidney disease, hypovitaminosis D, and mortality in the United StatesRajnish Mehrotra, Dulcie A Kermah, Isidro B Salusky, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 14, 2004
12/15-lipoxygenase inhibitors in diabetic nephropathy in the ratJun Ma, Rama Natarajan, Janine LaPage, et al.
Kidney International|February 9, 2005
Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruliZhong-Gao Xu, Tae-Hyun Yoo, Dong-Ryeol Ryu, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 5, 2010
Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuriaSharon G Adler, Sherwyn Schwartz, Mark E Williams, et al.
Glomerular Diseases|May 8, 2026
Prediabetes in Children and Adults with Glomerular DiseaseWilliam Rasmussen, Kayla Sifre, Nathaniel Putnam, et al.
Kidney International|August 17, 2016
The relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseasesMarie C Hogan, Heather N Reich, Peter J Nelson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 20, 2010
Examination of association with candidate genes for diabetic nephropathy in a Mexican American populationSulgi Kim, Hanna E Abboud, Madeleine V Pahl, et al.
Pageof 8